IDT Australia Limited (ASX:IDT)
0.0500
0.00 (0.00%)
At close: Mar 4, 2026
IDT Australia Revenue
IDT Australia had revenue of 9.72M AUD in the half year ending December 31, 2025, with 69.69% growth. This brings the company's revenue in the last twelve months to 19.00M, up 1.23% year-over-year. In the fiscal year ending June 30, 2025, IDT Australia had annual revenue of 19.77M with 40.99% growth.
Revenue (ttm)
19.00M
Revenue Growth
+1.23%
P/S Ratio
1.12
Revenue / Employee
190.04K
Employees
100
Market Cap
21.37M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 19.77M | 5.75M | 40.99% |
| Jun 30, 2024 | 14.02M | 7.03M | 100.67% |
| Jun 30, 2023 | 6.99M | -5.14M | -42.41% |
| Jun 30, 2022 | 12.13M | -4.80M | -28.34% |
| Jun 30, 2021 | 16.93M | 2.76M | 19.46% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vitura Health | 129.24M |
| Medical Developments International | 40.64M |
| Little Green Pharma | 38.49M |
| ECS Botanics Holdings | 19.36M |
| Peak Processing | 14.59M |
| Cann Group | 13.25M |
| Epsilon Healthcare | 9.39M |
| Syntara | 7.51M |